APPLIED MEDICAL DEVICES INC
8-K/A, 2000-02-28
NON-OPERATING ESTABLISHMENTS
Previous: NOONEY REAL PROPERTY INVESTORS TWO L P, 10-K, 2000-02-28
Next: GENERAL ELECTRIC S&S LONG TERM INTEREST FUND, NSAR-B, 2000-02-28



<PAGE>   1

                     U.S. Securities and Exchange Commission
                             Washington, D.C. 20549

                                    Form 8-K
                                Amendment No. 1

                                 Current Report
                       Pursuant to Section 13 or 15(d) of
                       The Securities Exchange Act of 1934


                          APPLIED MEDICAL DEVICES, INC.
        (Exact name of small business issuer as specified in its charter)

Date of Report:  February 25, 2000

           Colorado                     0-9064                  84-0789885
- -------------------------------      ------------         ----------------------
(State or other jurisdiction of      (Commission               (IRS Employer
 incorporation or organization)      File Number)         Identification Number)


        1722 Buffehr Creek Road,
             Vail, Colorado                                       81657
- ----------------------------------------                        ----------
(Address of principal executive offices)                        (Zip Code)

Issuer's telephone number, including area code                (970) 479-2800
                                                              --------------

Item 4.   Changes in Registrant's Certifying Accountant

     (a)    Previous independent accountants

     (i)    On February 24, 2000, BDO Seidman, LLP resigned as independent
            accountants for Applied Medical Devices, Inc.

     (ii)   The reports of BDO Seidman, LLP on the financial statements for the
            past two fiscal years contained no adverse opinion or disclaimer of
            opinion and were not qualified or modified as to uncertainty, audit
            scope or accounting principle.

     (iii)  The Registrant's Board of Directors participated in and approved the
            decision to change independent accountants.

     (iv)   In connection with its audits for the two most recent fiscal years
            and through February 24, 2000, there have been no disagreements with
            BDO Seidman, LLP on any matter of accounting principles or
            practices, financial statement disclosure, or auditing scope or
            procedure, which disagreements if not resolved to the satisfaction
            of BDO Seidman, LLP would have caused them to make reference thereto
            in their report on the financial statements for such years.


<PAGE>   2

     (v)  During the two most recent fiscal years and through February 24, 2000,
          there have been no reportable events (as defined in Regulation S-K
          Item 304(a)(1)(v)).

     (vi) The Registrant has requested that BDO Seidman LLP furnish it with a
          letter addressed to the SEC stating whether or not it agrees with the
          above statements. A copy of such letter, dated February 25, 2000, is
          filed as Exhibit 16 to this Form 8-K.

     (b)  New independent accountants

          The Registrant has engaged AJ. Robbins, P.C. as its new independent
          accountants as of February 24, 2000. During the two most recent fiscal
          years and through February 24, 2000, the Registrant has not consulted
          with AJ. Robbins, P.C. regarding either (i) the application of
          accounting principles to a specific transaction, either completed or
          proposed; or the type of audit opinion that might be rendered on the
          Registrant's financial statements, and either a written report was
          provided to the Registrant or oral advice was provided that AJ.
          Robbins, P.C. concluded was an important factor considered by the
          Registrant in reaching a decision as to the accounting, auditing or
          financial reporting issue; or (ii) any matter that was either the
          subject of a disagreement, as that term is defined in Item
          304(a)(1)(iv) of Regulation S-K and the related instructions to Item
          304 of Regulation S-K, or a reportable event, as that term is defined
          in Item 304(a)(1)(iv) of Regulation S-K.

Item 7.  Financial Statements and Exhibits

          (a)  Letter from BDO Seidman, LLP dated February 25, 2000.


                                  Page 2 of 3
                                    Form 8-K
<PAGE>   3

                                   SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.


                                           APPLIED MEDICAL DEVICES, INC.



February 25, 2000                          By:  /s/ Allan K. Lager
                                              ----------------------------------
                                              Allan K. Lager
                                              President



                                  Page 2 of 3
                                    Form 8-K

<PAGE>   4


                                 EXHIBIT INDEX

<TABLE>
<CAPTION>
EXHIBIT
NUMBER                    DESCRIPTION
- -------                   -----------
<S>                  <C>
Exhibit 99(a)        Letter from BDO Seidman, LLP dated February 25, 2000.
</TABLE>

<PAGE>   1
                                                                   EXHIBIT 99(a)


February 25, 2000


Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C. 20549

Ladies and Gentlemen:


Applied Medical Devices, Inc.
Commission File Number: 000-09064

We have read Item 4 of Applied Medical Devices, Inc.'s Form 8-K dated February
25, 2000 and are in agreement with the statements contained in paragraph 4(a)
therein.

Yours very truly,


/s/ BDO Seidman, LLP





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission